FASEB J. Mp Biomedicals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.07-104109.
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
fj.07-104109v1
23/1/45    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cristofanon, S.
Right arrow Articles by Diederich, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cristofanon, S.
Right arrow Articles by Diederich, M.
(The FASEB Journal. 2009;23:45-57.)
© 2009 FASEB

Oxidative, multistep activation of the noncanonical NF-{kappa}B pathway via disulfide Bcl-3/p50 complex

Silvia Cristofanon*,{dagger}, Franck Morceau*, A. Ivana Scovassi{ddagger}, Mario Dicato*, Lina Ghibelli{dagger},1 and Marc Diederich*,1

* Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Fondation Recherche sur le Cancer et les Maladies du Sang, Hôpital Kirchberg, Luxembourg;

{dagger} Dipartimento di Biologia, Università di Roma "Tor Vergata," Rome, Italy; and

{ddagger} Istituto di Genetica Molecolare Consiglio Nazionale delle Ricerche, Pavia, Italy

1 Correspondence: L.G., Dipartimento di Biologia, Università di Roma "Tor Vergata," Via della Ricerca Scientifica, 00133 Rome, Italy. E-mail: ghibelli{at}uniroma2.it; M.D., Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Fondation Recherche sur le Cancer et les Maladies du Sang, Hôpital Kirchberg, 9, rue Edward Steichen, L-2540 Luxembourg. E-mail: marc.diederich{at}lbmcc.lu

Buthionine sulfoximine (BSO) is a well-known inhibitor of glutathione synthesis, producing slow glutathione (GSH) depletion and oxidative stress; some "responder" cells avoid BSO-induced death by trans-activating the prosurvival protein Bcl-2. Here we show that BSO activates a noncanonical, inhibitory NF-{kappa}B- and p65-independent NF-{kappa}B pathway via a multistep process leading to the up-regulation of Bcl-2. The slow BSO-induced GSH depletion allows separation of two redox-related phases, namely, early thiol disequilibrium and late frank oxidative stress; each phase contributes to the progressive activation of a p50-p50 homodimer. The early phase, coinciding with substantial thiol depletion, produces a cytosolic preparative complex, consisting of p50 and its interactor Bcl-3 linked by interprotein disulfide bridges. The late phase, coinciding with reactive oxygen species production, is responsible, probably via p38 activation, for nuclear targeting of the complex and trans-activation of Bcl-2.—Cristofanon, S., Morceau, F., Scovassi, A. I., Dicato, M., Ghibelli, L., Diederich, M. Oxidative, multistep activation of the noncanonical NF-{kappa}B pathway via disulfide Bcl-3/p50 complex.


Key Words: glutathione • Bcl-2 • ROS • p38




This article has been cited by other articles:


Home page
J. Immunol.Home page
K. A. Khan, A. Coaquette, C. Davrinche, and G. Herbein
Bcl-3-Regulated Transcription from Major Immediate-Early Promoter of Human Cytomegalovirus in Monocyte-Derived Macrophages
J. Immunol., June 15, 2009; 182(12): 7784 - 7794.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.